Norges Bank’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-807,070
| Closed | -$51.3M | – | 374 |
|
|
2025
Q4 | $51.3M | Buy |
+807,070
| New | +$50.2M | 0.01% | 1008 |
|
|
2025
Q3 | – | Sell |
-1,184,072
| Closed | -$39.1M | – | 418 |
|
|
2025
Q2 | $39.1M | Buy |
1,184,072
+7,153
| +0.6% | +$249K | ﹤0.01% | 1048 |
|
|
2025
Q1 | $47.3M | Buy |
1,176,919
+187,198
| +19% | +$8.6M | 0.01% | 961 |
|
|
2024
Q4 | $46.6M | Sell |
989,721
-2,916
| -0.3% | -$151K | 0.01% | 989 |
|
|
2024
Q3 | $52.4M | Buy |
992,637
+192,973
| +24% | +$10.8M | 0.01% | 952 |
|
|
2024
Q2 | $43.3M | Sell |
799,664
-183,097
| -19% | -$11.1M | 0.01% | 961 |
|
|
2024
Q1 | $68.9M | Buy |
982,761
+260,532
| +36% | +$20.2M | 0.01% | 794 |
|
|
2023
Q4 | $60.3M | Sell |
722,229
-107,278
| -13% | -$3.88M | 0.01% | 819 |
|
|
2023
Q3 | $24.4M | Buy |
829,507
+78,057
| +10% | +$2.6M | 0.01% | 1151 |
|
|
2023
Q2 | $24.5M | Buy |
751,450
+13,291
| +2% | +$492K | ﹤0.01% | 1169 |
|
|
2023
Q1 | $26M | Sell |
738,159
-101,197
| -12% | -$4.13M | 0.01% | 1149 |
|
|
2022
Q4 | $38.5M | Buy |
839,356
+15,860
| +2% | +$682K | 0.01% | 919 |
|
|
2022
Q3 | $39.9M | Buy |
823,496
+70,762
| +9% | +$3.41M | 0.01% | 867 |
|
|
2022
Q2 | $29.6M | Buy |
752,734
+156,355
| +26% | +$6.29M | 0.01% | 1039 |
|
|
2022
Q1 | $22M | Buy |
+596,379
| New | +$21.2M | ﹤0.01% | 1352 |
|
|
2020
Q4 | – | Sell |
-207,200
| Closed | -$4.49M | – | 2125 |
|
|
2020
Q3 | $4.49M | Hold |
207,200
| – | – | ﹤0.01% | 1880 |
|
|
2020
Q2 | $4.88M | Buy |
+207,200
| New | +$3.89M | ﹤0.01% | 1867 |
|
|
2017
Q1 | – | Sell |
-80,321
| Closed | -$976K | – | 2148 |
|
|
2016
Q4 | $976K | Buy |
+80,321
| New | +$852K | ﹤0.01% | 2055 |
|
Other funds holding CYTK
VPM
VCM
ACA
